I am enrolled in Signatere test which is appropriate only when you are pronounced NED.
It is a blood test being used for other cancers that can detect the DNA of your cancer type in the bloodstream prior to tumors forming.

I was identified with the ATM gene mutation. I had ovarian cancer in 2007 and DCIS (stage 0) breast cancer in November, and those together prompted the genetic testing. I was undergoing baseline testing to set up a screening regimen for pancreatic in March when the tumor marker blood tests discovered I already have it; I'm just not very symptomatic yet. I was told there aren't any current trials involving the ATM mutation. We have initiated next-gen sequencing of the tumor tissue's DNA to determine the best chemo regimen; meanwhile, we'll start chemo with modified Folfirinox. There is a website that lists clinical trials, but I would probably just ask Dr. Google (haha) to search for clinical trials involving your specific genetic finding. That said, I was told I qualify for a number of supportive clinical trials, and so far I agreed to one, which is looking to see whether people with specific genetic markers have more or less trouble with GI upsets during chemo.

I agree--dealing with this diagnosis is a roller coaster. It is difficult to find positives in the middle of all the horror and negative findings. I am so glad to have found this message board (I"m not a Mayo patient) because I think it will really help boost my spirits.